MENU

ESLA Estrella Immunopharma Forecast, Technical & Fundamental Analysis

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company... Show more

ESLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ESLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ESLA is expected to report earnings to rise 280.00% to -18 cents per share on December 02

Estrella Immunopharma ESLA Stock Earnings Reports
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.12
Q1'26
Beat
by $0.13
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.05
The last earnings report on September 02 showed earnings per share of -5 cents, beating the estimate of -17 cents. With 7.09K shares outstanding, the current market capitalization sits at 29.35M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 318-9098
Employees
N/A
Web
https://www.estrellabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASTI2.860.03
+1.24%
Ascent Solar Technologies Inc
EYE17.290.16
+0.93%
National Vision Holdings
UBSI47.220.27
+0.58%
United Bankshares
SCHW107.25-0.08
-0.07%
Charles Schwab Corp (The)
KLC2.37-0.14
-5.58%
KinderCare Learning Companies Inc

ESLA and Stocks

Correlation & Price change

A.I.dvisor tells us that ESLA and PRLD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and PRLD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
+3.09%
PRLD - ESLA
28%
Poorly correlated
-1.71%
ARMP - ESLA
26%
Poorly correlated
+2.87%
BMEA - ESLA
25%
Poorly correlated
+2.35%
LIMN - ESLA
23%
Poorly correlated
-4.41%
FATE - ESLA
23%
Poorly correlated
-0.86%
More